Specialty Pharmacy

Coffee appears to confer a number of protective effects against liver disease.

Nanoparticles found to stop disease progression in a model of chronic MS.

HIV viral reservoir widely considered the last barrier to a cure.

Uninsured rate decreased from 14.4% to 9.1% nationally in first 9 months of 2015.

The drug is the first biosimilar monoclonal antibody to be considered by the FDA.

Connecticut man achieves remission via Revlimid therapy while bolstered by the love of his wife and children.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the relationship between specialty pharmacies and accountable care organizations.

Researchers find the amplification and mutation of human epidermal growth factor receptor 2 should be treated separately.

Blincyto treats adult patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor ALL.

Johns Hopkins will be the first hospital in the US to administer an HIV-positive kidney transplant and the first in the world to perform an HIV-positive liver transplant.

Patients with allergies and asthma have a deficiency in a protective protein called A20, which causes them to suffer more from allergens.

Treatment errors in HIV therapy injure thousands of patients annually.

More than 4 million consumers in HealthCare.gov states signed up for coverage this year.

Daklinza is a direct-acting antiviral agent for the treatment of hepatitis C virus.

Novel therapeutic approach for multiple myeloma causes shows promising total cure rates.

Natalizumab linked to increased risk biomarkers for virus that can lead to potentially fatal condition.

Encapsulated human islet cells could improve maintenance of blood sugar levels in patients with diabetes.

RA patients who do yoga demonstrate benefits in health related quality of life measures.

Emend found to provide a greater delay in nausea and vomiting from cancer treatment than other medicines.

App can facilitate early detection and treatment of symptoms of chronic obstructive pulmonary disease.

Early detection is key in reducing the risk of heart failure in patients with cancer.

Testimony from public speakers at FDA advisory committee meetings under increased scrutiny.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the potential of biosimilars to reduce the cost burden of specialty pharmaceuticals.

Use of 3-D technology explains how cancerous cells recruit healthy cells.

Nearly 15% of colorectal cancers diagnosed before the recommended screening age of 50.

Targeting enzyme found to slow progression of MS in human cells.

Cistus incanus found to inhibit viral proteins from infecting healthy cells.

Top news of the week in oncology drug development.